Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (23)

2023

  1. Use of 125I seeds in the surgical management of a complex oncological case

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 2, pp. 116-118

2020

  1. Assessing immunotherapy with functional and molecular imaging and radiomics

    Radiographics, Vol. 40, Núm. 7, pp. 1987-2010

  2. Intensity normalization methods in brain FDG-PET quantification

    NeuroImage, Vol. 222

2015

  1. Presence of intramammary lymph nodes in the preoperative lymphoscintigraphy to locate the sentinel lymph node. Clinical significance

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 34, Núm. 2, pp. 83-88

2014

  1. Aberrant lymphatic drainage from a melanoma located in epigastric area

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 6, pp. 390-391

  2. Analytical, experimental, and Monte Carlo system response matrix for pinhole SPECT reconstruction

    Medical Physics, Vol. 41, Núm. 3

  3. The performance of a hybrid analytical-Monte Carlo system response matrix in pinhole SPECT reconstruction

    Physics in Medicine and Biology, Vol. 59, Núm. 24, pp. 7573-7585

2008

  1. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: A multicenter study

    Sleep Medicine, Vol. 9, Núm. 6, pp. 660-666

2002

  1. Conferencia de Consenso sobre el ganglio centinela en el cáncer de mama. Valencia, 8 de Octubre de 2001. Organizada por la Sociedad Española de Cirugía Oncológica

    Clinical and Translational Oncology

1999

  1. Multicenter evaluation of the Elecsys® CA 125 II assay

    Anticancer Research

1998

  1. Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA 125

    Clinical Chemistry, Vol. 44, Núm. 12, pp. 2530-2536

1988

  1. Clinical utility of prostatic specific antigen and prostatic acid phosphatase serum levels in monitoring prostate cancer.

    The International journal of biological markers, Vol. 3, Núm. 1, pp. 23-28

1987

  1. Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: Are they helpful in staging prostatic cancer

    Journal of Urology, Vol. 137, Núm. 5, pp. 891-893

  2. CA 50 serum levels in patients with liver diseases.

    The International journal of biological markers, Vol. 2, Núm. 3, pp. 207-208

1986

  1. Evidence of a relationship between high serum CA 125 and liver failure pattern in cirrhotic patients without ascitis and jaundice.

    The International journal of biological markers, Vol. 1, Núm. 1, pp. 55-56

1983

  1. Influence of exercise on serum levels of myoglobin measured by radioimmunoassay

    European Journal of Nuclear Medicine, Vol. 8, Núm. 4, pp. 159-161

1980

  1. ESTUDIO DE LA CONCENTRACION PLASMATICA DE HORMONA DE CRECIMIENTO EN PACIENTES CON TUMORES DEL APARATO RESPIRATORIO

    Radiologia, Vol. 22, Núm. 2, pp. 123-128

  2. Simultaneous plasma determination of CEA, HCG-beta and beta-2- microglobulin in patients with nontrophoblastic tumors

    Tumori, Vol. 66, Núm. 3, pp. 305-309

1979

  1. CARCINOEMBRYONIC ANTIGEN IN LIVER DISEASE

    The Lancet

  2. UTILIDAD CLINICA DE LA DOSIFICACION SIMULTANEA DE CEA Y HCG-BETA EN PACIENTES CON TUMORES NO TROFOBLASTICOS. ESTUDIO PRELIMINAR

    Radiologia, Vol. 21, Núm. 3, pp. 201-204